Global Gene Therapy-based Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Gene Therapy-based Drug market size is expected to reach $ 32040 million by 2030, rising at a market growth of 19.3% CAGR during the forecast period (2024-2030).

The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

This report studies the global Gene Therapy-based Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Therapy-based Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy-based Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gene Therapy-based Drug total market, 2019-2030, (USD Million)
Global Gene Therapy-based Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Gene Therapy-based Drug total market, key domestic companies and share, (USD Million)
Global Gene Therapy-based Drug revenue by player and market share 2019-2024, (USD Million)
Global Gene Therapy-based Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Gene Therapy-based Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Gene Therapy-based Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy-based Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gene Therapy-based Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gene Therapy-based Drug Market, Segmentation by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Global Gene Therapy-based Drug Market, Segmentation by Application
    Neurological Diseases
    Cancer
    Other

Companies Profiled:
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

Key Questions Answered
1. How big is the global Gene Therapy-based Drug market?
2. What is the demand of the global Gene Therapy-based Drug market?
3. What is the year over year growth of the global Gene Therapy-based Drug market?
4. What is the total value of the global Gene Therapy-based Drug market?
5. Who are the major players in the global Gene Therapy-based Drug market?

Table of Contents

1 Supply Summary
    1.1 Gene Therapy-based Drug Introduction
    1.2 World Gene Therapy-based Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Gene Therapy-based Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Gene Therapy-based Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Gene Therapy-based Drug Market Size (2019-2030)
        1.3.3 China Gene Therapy-based Drug Market Size (2019-2030)
        1.3.4 Europe Gene Therapy-based Drug Market Size (2019-2030)
        1.3.5 Japan Gene Therapy-based Drug Market Size (2019-2030)
        1.3.6 South Korea Gene Therapy-based Drug Market Size (2019-2030)
        1.3.7 ASEAN Gene Therapy-based Drug Market Size (2019-2030)
        1.3.8 India Gene Therapy-based Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gene Therapy-based Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gene Therapy-based Drug Major Market Trends

2 Demand Summary
    2.1 World Gene Therapy-based Drug Consumption Value (2019-2030)
    2.2 World Gene Therapy-based Drug Consumption Value by Region
        2.2.1 World Gene Therapy-based Drug Consumption Value by Region (2019-2024)
        2.2.2 World Gene Therapy-based Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Gene Therapy-based Drug Consumption Value (2019-2030)
    2.4 China Gene Therapy-based Drug Consumption Value (2019-2030)
    2.5 Europe Gene Therapy-based Drug Consumption Value (2019-2030)
    2.6 Japan Gene Therapy-based Drug Consumption Value (2019-2030)
    2.7 South Korea Gene Therapy-based Drug Consumption Value (2019-2030)
    2.8 ASEAN Gene Therapy-based Drug Consumption Value (2019-2030)
    2.9 India Gene Therapy-based Drug Consumption Value (2019-2030)

3 World Gene Therapy-based Drug Companies Competitive Analysis
    3.1 World Gene Therapy-based Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Gene Therapy-based Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Gene Therapy-based Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Gene Therapy-based Drug in 2023
    3.3 Gene Therapy-based Drug Company Evaluation Quadrant
    3.4 Gene Therapy-based Drug Market: Overall Company Footprint Analysis
        3.4.1 Gene Therapy-based Drug Market: Region Footprint
        3.4.2 Gene Therapy-based Drug Market: Company Product Type Footprint
        3.4.3 Gene Therapy-based Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Gene Therapy-based Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Gene Therapy-based Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Gene Therapy-based Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Gene Therapy-based Drug Consumption Value Comparison
        4.2.1 United States VS China: Gene Therapy-based Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Gene Therapy-based Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Gene Therapy-based Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Gene Therapy-based Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Gene Therapy-based Drug Revenue, (2019-2024)
    4.4 China Based Companies Gene Therapy-based Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Gene Therapy-based Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Gene Therapy-based Drug Revenue, (2019-2024)
    4.5 Rest of World Based Gene Therapy-based Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Gene Therapy-based Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Gene Therapy-based Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Gene Therapy-based Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Viral Gene Delivery System
        5.2.2 Non-viral Gene Delivery System
    5.3 Market Segment by Type
        5.3.1 World Gene Therapy-based Drug Market Size by Type (2019-2024)
        5.3.2 World Gene Therapy-based Drug Market Size by Type (2025-2030)
        5.3.3 World Gene Therapy-based Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Gene Therapy-based Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Neurological Diseases
        6.2.2 Cancer
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Gene Therapy-based Drug Market Size by Application (2019-2024)
        6.3.2 World Gene Therapy-based Drug Market Size by Application (2025-2030)
        6.3.3 World Gene Therapy-based Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Biogen
        7.1.1 Biogen Details
        7.1.2 Biogen Major Business
        7.1.3 Biogen Gene Therapy-based Drug Product and Services
        7.1.4 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Biogen Recent Developments/Updates
        7.1.6 Biogen Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Gene Therapy-based Drug Product and Services
        7.2.4 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Details
        7.3.2 Gilead Sciences Major Business
        7.3.3 Gilead Sciences Gene Therapy-based Drug Product and Services
        7.3.4 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Gilead Sciences Recent Developments/Updates
        7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Details
        7.4.2 Sarepta Therapeutics Major Business
        7.4.3 Sarepta Therapeutics Gene Therapy-based Drug Product and Services
        7.4.4 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Sarepta Therapeutics Recent Developments/Updates
        7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.5 Alnylam Pharmaceuticals
        7.5.1 Alnylam Pharmaceuticals Details
        7.5.2 Alnylam Pharmaceuticals Major Business
        7.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Services
        7.5.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
        7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Amgen
        7.6.1 Amgen Details
        7.6.2 Amgen Major Business
        7.6.3 Amgen Gene Therapy-based Drug Product and Services
        7.6.4 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Amgen Recent Developments/Updates
        7.6.6 Amgen Competitive Strengths & Weaknesses
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Details
        7.7.2 Spark Therapeutics Major Business
        7.7.3 Spark Therapeutics Gene Therapy-based Drug Product and Services
        7.7.4 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Spark Therapeutics Recent Developments/Updates
        7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.8 Akcea Therapeutics
        7.8.1 Akcea Therapeutics Details
        7.8.2 Akcea Therapeutics Major Business
        7.8.3 Akcea Therapeutics Gene Therapy-based Drug Product and Services
        7.8.4 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Akcea Therapeutics Recent Developments/Updates
        7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
    7.9 bluebird bio
        7.9.1 bluebird bio Details
        7.9.2 bluebird bio Major Business
        7.9.3 bluebird bio Gene Therapy-based Drug Product and Services
        7.9.4 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 bluebird bio Recent Developments/Updates
        7.9.6 bluebird bio Competitive Strengths & Weaknesses
    7.10 Sunway Biotech
        7.10.1 Sunway Biotech Details
        7.10.2 Sunway Biotech Major Business
        7.10.3 Sunway Biotech Gene Therapy-based Drug Product and Services
        7.10.4 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Sunway Biotech Recent Developments/Updates
        7.10.6 Sunway Biotech Competitive Strengths & Weaknesses
    7.11 SIBIONO
        7.11.1 SIBIONO Details
        7.11.2 SIBIONO Major Business
        7.11.3 SIBIONO Gene Therapy-based Drug Product and Services
        7.11.4 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 SIBIONO Recent Developments/Updates
        7.11.6 SIBIONO Competitive Strengths & Weaknesses
    7.12 AnGes
        7.12.1 AnGes Details
        7.12.2 AnGes Major Business
        7.12.3 AnGes Gene Therapy-based Drug Product and Services
        7.12.4 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 AnGes Recent Developments/Updates
        7.12.6 AnGes Competitive Strengths & Weaknesses
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Details
        7.13.2 Orchard Therapeutics Major Business
        7.13.3 Orchard Therapeutics Gene Therapy-based Drug Product and Services
        7.13.4 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Orchard Therapeutics Recent Developments/Updates
        7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses
    7.14 Human Stem Cells Institute
        7.14.1 Human Stem Cells Institute Details
        7.14.2 Human Stem Cells Institute Major Business
        7.14.3 Human Stem Cells Institute Gene Therapy-based Drug Product and Services
        7.14.4 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Human Stem Cells Institute Recent Developments/Updates
        7.14.6 Human Stem Cells Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gene Therapy-based Drug Industry Chain
    8.2 Gene Therapy-based Drug Upstream Analysis
    8.3 Gene Therapy-based Drug Midstream Analysis
    8.4 Gene Therapy-based Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gene Therapy-based Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Gene Therapy-based Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Gene Therapy-based Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Gene Therapy-based Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Gene Therapy-based Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Gene Therapy-based Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Gene Therapy-based Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Gene Therapy-based Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Gene Therapy-based Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Gene Therapy-based Drug Players in 2023
    Table 12. World Gene Therapy-based Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Gene Therapy-based Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Gene Therapy-based Drug Player
    Table 15. Gene Therapy-based Drug Market: Company Product Type Footprint
    Table 16. Gene Therapy-based Drug Market: Company Product Application Footprint
    Table 17. Gene Therapy-based Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Gene Therapy-based Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Gene Therapy-based Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Gene Therapy-based Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Gene Therapy-based Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Gene Therapy-based Drug Revenue Market Share (2019-2024)
    Table 23. China Based Gene Therapy-based Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Gene Therapy-based Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Gene Therapy-based Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Gene Therapy-based Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Gene Therapy-based Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Gene Therapy-based Drug Revenue Market Share (2019-2024)
    Table 29. World Gene Therapy-based Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Gene Therapy-based Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Gene Therapy-based Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Gene Therapy-based Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Gene Therapy-based Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Gene Therapy-based Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Biogen Basic Information, Area Served and Competitors
    Table 36. Biogen Major Business
    Table 37. Biogen Gene Therapy-based Drug Product and Services
    Table 38. Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Biogen Recent Developments/Updates
    Table 40. Biogen Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Gene Therapy-based Drug Product and Services
    Table 44. Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Gilead Sciences Basic Information, Area Served and Competitors
    Table 48. Gilead Sciences Major Business
    Table 49. Gilead Sciences Gene Therapy-based Drug Product and Services
    Table 50. Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Gilead Sciences Recent Developments/Updates
    Table 52. Gilead Sciences Competitive Strengths & Weaknesses
    Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 54. Sarepta Therapeutics Major Business
    Table 55. Sarepta Therapeutics Gene Therapy-based Drug Product and Services
    Table 56. Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Sarepta Therapeutics Recent Developments/Updates
    Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
    Table 60. Alnylam Pharmaceuticals Major Business
    Table 61. Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Services
    Table 62. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
    Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    Table 65. Amgen Basic Information, Area Served and Competitors
    Table 66. Amgen Major Business
    Table 67. Amgen Gene Therapy-based Drug Product and Services
    Table 68. Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Amgen Recent Developments/Updates
    Table 70. Amgen Competitive Strengths & Weaknesses
    Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 72. Spark Therapeutics Major Business
    Table 73. Spark Therapeutics Gene Therapy-based Drug Product and Services
    Table 74. Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Spark Therapeutics Recent Developments/Updates
    Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
    Table 78. Akcea Therapeutics Major Business
    Table 79. Akcea Therapeutics Gene Therapy-based Drug Product and Services
    Table 80. Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Akcea Therapeutics Recent Developments/Updates
    Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
    Table 83. bluebird bio Basic Information, Area Served and Competitors
    Table 84. bluebird bio Major Business
    Table 85. bluebird bio Gene Therapy-based Drug Product and Services
    Table 86. bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. bluebird bio Recent Developments/Updates
    Table 88. bluebird bio Competitive Strengths & Weaknesses
    Table 89. Sunway Biotech Basic Information, Area Served and Competitors
    Table 90. Sunway Biotech Major Business
    Table 91. Sunway Biotech Gene Therapy-based Drug Product and Services
    Table 92. Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Sunway Biotech Recent Developments/Updates
    Table 94. Sunway Biotech Competitive Strengths & Weaknesses
    Table 95. SIBIONO Basic Information, Area Served and Competitors
    Table 96. SIBIONO Major Business
    Table 97. SIBIONO Gene Therapy-based Drug Product and Services
    Table 98. SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. SIBIONO Recent Developments/Updates
    Table 100. SIBIONO Competitive Strengths & Weaknesses
    Table 101. AnGes Basic Information, Area Served and Competitors
    Table 102. AnGes Major Business
    Table 103. AnGes Gene Therapy-based Drug Product and Services
    Table 104. AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. AnGes Recent Developments/Updates
    Table 106. AnGes Competitive Strengths & Weaknesses
    Table 107. Orchard Therapeutics Basic Information, Area Served and Competitors
    Table 108. Orchard Therapeutics Major Business
    Table 109. Orchard Therapeutics Gene Therapy-based Drug Product and Services
    Table 110. Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Orchard Therapeutics Recent Developments/Updates
    Table 112. Human Stem Cells Institute Basic Information, Area Served and Competitors
    Table 113. Human Stem Cells Institute Major Business
    Table 114. Human Stem Cells Institute Gene Therapy-based Drug Product and Services
    Table 115. Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Gene Therapy-based Drug Upstream (Raw Materials)
    Table 117. Gene Therapy-based Drug Typical Customers
List of Figure
    Figure 1. Gene Therapy-based Drug Picture
    Figure 2. World Gene Therapy-based Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Gene Therapy-based Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Gene Therapy-based Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Gene Therapy-based Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Gene Therapy-based Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Gene Therapy-based Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Gene Therapy-based Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Gene Therapy-based Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Gene Therapy-based Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy-based Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy-based Drug Markets in 2023
    Figure 27. United States VS China: Gene Therapy-based Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Gene Therapy-based Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Gene Therapy-based Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Gene Therapy-based Drug Market Size Market Share by Type in 2023
    Figure 31. Viral Gene Delivery System
    Figure 32. Non-viral Gene Delivery System
    Figure 33. World Gene Therapy-based Drug Market Size Market Share by Type (2019-2030)
    Figure 34. World Gene Therapy-based Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Gene Therapy-based Drug Market Size Market Share by Application in 2023
    Figure 36. Neurological Diseases
    Figure 37. Cancer
    Figure 38. Other
    Figure 39. Gene Therapy-based Drug Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute